Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progression of Alzheimer disease in Europe: data from the European ICTUS study.
Vellas B, Hausner L, Frölich L, Cantet C, Gardette V, Reynish E, Gillette S, Agüera-Morales E, Auriacombe S, Boada M, Bullock R, Byrne J, Camus V, Cherubini A, Eriksdotter-Jönhagen M, Frisoni GB, Hasselbalch S, Jones RW, Martinez-Lage P, Rikkert MO, Tsolaki M, Ousset PJ, Pasquier F, Ribera-Casado JM, Rigaud AS, Robert P, Rodriguez G, Salmon E, Salva A, Scheltens P, Schneider A, Sinclair A, Spiru L, Touchon J, Zekry D, Winblad B, Andrieu S. Vellas B, et al. Among authors: frolich l. Curr Alzheimer Res. 2012 Oct;9(8):902-12. doi: 10.2174/156720512803251066. Curr Alzheimer Res. 2012. PMID: 22742853
Realistic expectations for treatment success in Alzheimer's disease.
Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M. Geldmacher DS, et al. Among authors: frolich l. J Nutr Health Aging. 2006 Sep-Oct;10(5):417-29. J Nutr Health Aging. 2006. PMID: 17066215 Review.
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study.
Visser PJ, Verhey FR, Boada M, Bullock R, De Deyn PP, Frisoni GB, Frolich L, Hampel H, Jolles J, Jones R, Minthon L, Nobili F, Olde Rikkert M, Ousset PJ, Rigaud AS, Scheltens P, Soininen H, Spiru L, Touchon J, Tsolaki M, Vellas B, Wahlund LO, Wilcock G, Winblad B. Visser PJ, et al. Among authors: frolich l. Neuroepidemiology. 2008;30(4):254-65. doi: 10.1159/000135644. Epub 2008 Jun 2. Neuroepidemiology. 2008. PMID: 18515975 Free PMC article.
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
van de Pol LA, Verhey F, Frisoni GB, Tsolaki M, Papapostolou P, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, Knol DL, Barkhof F, Scheltens P, Visser PJ. van de Pol LA, et al. Among authors: frolich l. J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1069-74. doi: 10.1136/jnnp.2008.158881. Epub 2009 Jun 18. J Neurol Neurosurg Psychiatry. 2009. PMID: 19541689 Free article.
Consensus statement on dementia education and training in Europe.
Tsolaki M, Papaliagkas V, Anogianakis G, Bernabei R, Emre M, Frolich L, Visser PJ, Michel JP, Pirttila T, Olde Rikkert M, Soininen H, Sobow T, Vellas B, Verhey F, Winblad B; European Alzheimer Disease Consortium. Tsolaki M, et al. Among authors: frolich l. J Nutr Health Aging. 2010 Feb;14(2):131-5. doi: 10.1007/s12603-009-0238-z. J Nutr Health Aging. 2010. PMID: 20126961 Free article.
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T. Emre M, et al. Among authors: frolich l. CNS Neurosci Ther. 2010 Aug;16(4):246-53. doi: 10.1111/j.1755-5949.2010.00141.x. Epub 2010 Apr 16. CNS Neurosci Ther. 2010. PMID: 20370805 Free PMC article. Review.
328 results